Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 15, 2010
On March 7, 2006, in room 2205 of the (then new) White Oak FDA facility, Prof. Trevor Marshall delivered a lecture in FDA's Center for Drug Evaluation and Review (CDER) "Visiting Professor" series. The topic was how ARBs and Statins affect a lot more of the body than just the receptors they are thought to target ('dirty drugs", in the words of one FDA participant).